/ Print /

Business Strategy

Managed Care State of the Industry Survey 2016As 2016 comes to a close, how do healthcare leaders feel about the state of the industry? Here’s your chance to find out.
Four things to know about the 21st Century Cures ActThe 21st Century Cures Act, a landmark medical research bill, offers healthcare executives a promising future.
Health Execs: Who I respect most in the industryIndustry leaders share their sources of inspiration.
What billions in lost pharma revenue means for managed carePharmaceutical manufacturer relationships and next-gen value based contracts are primed to accelerate value-derivation from your drug spend.
Eight ways Trump could change MedicaidExperts share their ideas on how President-elect Trump could change the single largest source of insurance in the country.
New president new path forward for managed care plansIn the aftermath of the presidential election, health policy experts have less to go on than they have after any election in memory.
Top 2017 challenges healthcare executives face
Top 2017 challenges healthcare executives faceResults from Managed Healthcare Executive’s annual State of the Industry Survey reveal which issues will hit managed healthcare hardest in 2017.
Five things to know about Trump’s health leadership picksPresident-elect Trump named Tom Price and Seema Verma to lead HHS and CMS, respectively. Here’s what you should know about them.
Opinion: Health reformers overlook areas that could reduce most costsNone of Trump’s plans, such as repealing parts of Obamacare or expanding HSAs, will rein in the rising cost of healthcare.
Top barriers to fully utilizing precision medicine biomarkersAs development of molecular biomarkers hastens, administrators, clinicians and regulators are working to organize and define biomarkers’ appropriate roles in clinical care—and discussing how to efficiently share the massive amounts of genomic data that will result.